The article discusses a prospective evaluation conducted by 16 diabetes specialists in Spain on the effectiveness of two advanced hybrid closed-loop insulin delivery systems, MM780G with SmartGuard and Tandem t:slimX2 with Control-IQ. The study involved 150 patients from 14 centers, lasting for 3 months, to assess diabetes control and user satisfaction. Both systems showed a significant improvement in glucose control, with Control-IQ users experiencing the greatest reduction in diabetes-related anxiety. The systems work by constantly measuring glucose levels and automatically adjusting insulin delivery to manage highs and lows. International scientific societies recommend these closed-loop systems as the standard of care for type 1 diabetes due to their effectiveness over conventional insulin therapy. However, the adoption of these devices in Spain is limited, mainly due to barriers such as cost.
翻譯成其他語言
從原文內容
www.medscape.com
從以下內容提煉的關鍵洞見
by Pura C. Roy 於 www.medscape.com 01-12-2024
https://www.medscape.com/viewarticle/automatic-hybrid-insulin-delivery-systems-help-manage-t1d-2024a10000t0深入探究